Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CYTOKINETICS INCCYTK · Entity 3528 | Director · President & CEO | October 12, 2026 | October 13, 2026 |
| Gamida Cell Ltd.GMDA · Entity 94655 | Director | February 08, 2023 | February 11, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CYTOKINETICS INC
Report date October 12, 2026 · Filed October 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 278,544 |
Ending reported balance
After 2026-10-12 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-10-12 · Exercise / conversion · Acquired 7,500 · Balance 286,044 Row 2 · 2026-10-12 · Sale · Disposed 7,500 · Balance 278,544 |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.60 · Expires 2027-02-28 | Direct | 141,745 |
Reported balance
After 2026-10-12 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-10-12 · Exercise / conversion · Disposed 7,500 · Balance 141,745 |
| Common StockSEC Table I · non-derivative | Indirectby Trust 1. Beneficial Ownership disclaimed. | 2,083 |
Reported balance
Holding disclosure · report date 2026-10-12 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 2,083 F1: Shares held by The Bridget Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares. |
| Common StockSEC Table I · non-derivative | Indirectby Trust 2. Beneficial Ownership Disclaimed. | 2,083 |
Reported balance
Holding disclosure · report date 2026-10-12 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 2,083 F2: Shares held by The Brittany Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares held by The Bridget Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares.
F2: Shares held by The Brittany Blum 2003 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the Shares.
Gamida Cell Ltd.
Report date February 08, 2023 · Filed February 11, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 96,500 |
Ending reported balance
After 2023-02-08 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-02-08 · Grant · Acquired 28,300 · Balance 82,300 F1: Represents a restricted share unit award, which shall vest on February 8, 2024, subject to the Reporting Person's continuous service through such vesting date. Row 2 · 2023-02-08 · Grant · Acquired 14,200 · Balance 96,500 F1: Represents a restricted share unit award, which shall vest on February 8, 2024, subject to the Reporting Person's continuous service through such vesting date. |
| Share Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.59 · Expires 2033-02-07 | Direct | 56,600 |
Reported balance
After 2023-02-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-02-08 · Grant · Acquired 56,600 · Balance 56,600 F2: This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on May 8, 2023, subject to the Reporting Person's continuous service through each such vesting date. |
| Share Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.59 · Expires 2033-02-07 | Direct | 28,300 |
Reported balance
After 2023-02-08 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-02-08 · Grant · Acquired 28,300 · Balance 28,300 F2: This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on May 8, 2023, subject to the Reporting Person's continuous service through each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted share unit award, which shall vest on February 8, 2024, subject to the Reporting Person's continuous service through such vesting date.
F2: This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on May 8, 2023, subject to the Reporting Person's continuous service through each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 12, 2026 Filed Oct 13, 2026 20:00 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001061983-26-000099 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,745 Underlying: Common Stock · 7,500 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 12, 2026 Filed Oct 13, 2026 20:00 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 7,500 | $62.88 | $471,600.00 |
DisclosureSEC source: 0001061983-26-000099 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 278,544 Read SEC document |
| October 12, 2026 Filed Oct 13, 2026 20:00 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 7,500 | $10.60 | $79,500.00 |
DisclosureSEC source: 0001061983-26-000099 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 286,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 28, 2026 Filed Sep 28, 2026 20:54 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001061983-26-000097 · form4.xml · derivative · entry 6 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 149,245 Underlying: Common Stock · 7,500 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 28, 2026 Filed Sep 28, 2026 20:54 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 7,500 | $65.46 | $490,950.00 |
DisclosureSEC source: 0001061983-26-000097 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 278,544 Read SEC document |
| September 28, 2026 Filed Sep 28, 2026 20:54 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 7,500 | $10.60 | $79,500.00 |
DisclosureSEC source: 0001061983-26-000097 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 286,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2026 Filed Sep 15, 2026 21:20 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 97,926 | $69.33 | $6,789,209.58 |
DisclosureSEC source: 0001061983-26-000094 · form4.xml · nonDerivative · entry 6 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Indirect · by Trust 3. Beneficial Ownership Disclaimed. Disclosed balance after: 0 F6 · kind: Sale of shares of common stock by The Bridget Blum 2026 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the shares sold or the proceeds thereof. Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 21:20 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001061983-26-000094 · form4.xml · derivative · entry 9 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 156,745 Underlying: Common Stock · 7,500 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · kind: Exercise of stock options. Transaction is pursuant to a trading plan adopted by the reporting person intended to satisfy the conditions of Rule 10b5-1(c). Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 21:20 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GiftCommon Stock | 97,926 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-26-000094 · form4.xml · nonDerivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Indirect · by Trust 3. Beneficial Ownership Disclaimed. Disclosed balance after: 97,926 F5 · kind: Acquisition of shares by The Bridget Blum 2026 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the shares held by the aforementioned trust. Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 21:20 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GiftCommon Stock | 97,926 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-26-000094 · form4.xml · nonDerivative · entry 4 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 278,544 F4 · kind: Transfer of shares of common stock to The Bridget Blum 2026 Irrevocable Trust, of which reporting person is a co-trustee. Reporting person disclaims any beneficial ownership interest in the shares held by the aforementioned trust upon completion of the gift transfer. Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 21:20 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GiftCommon Stock | 1,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-26-000094 · form4.xml · nonDerivative · entry 3 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 376,470 F3 · kind: Charitable gift. Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 21:20 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 7,500 | $73.44 | $550,800.00 |
DisclosureSEC source: 0001061983-26-000094 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 377,820 F2 · kind: Sale of shares of common stock acquired upon exercise of stock options. Transaction is pursuant to a trading plan adopted by the reporting person intended to satisfy the conditions of Rule 10b5-1(c). Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 21:20 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 7,500 | $10.60 | $79,500.00 |
DisclosureSEC source: 0001061983-26-000094 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 385,320 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Acquisition of shares of common stock upon exercise of stock options. Transaction is pursuant to a trading plan adopted by the reporting person intended to satisfy the conditions of Rule 10b5-1(c). Read SEC document |
| August 31, 2026 Filed Aug 31, 2026 20:55 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001061983-26-000089 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 164,245 Underlying: Common Stock · 7,500 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2026 Filed Aug 31, 2026 20:55 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 7,500 | $70.24 | $526,800.00 |
DisclosureSEC source: 0001061983-26-000089 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 377,820 Read SEC document |
| August 31, 2026 Filed Aug 31, 2026 20:55 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 7,500 | $10.60 | $79,500.00 |
DisclosureSEC source: 0001061983-26-000089 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 385,320 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2026 Filed Aug 10, 2026 21:11 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001061983-26-000087 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 171,745 Underlying: Common Stock · 7,500 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2026 Filed Aug 10, 2026 21:11 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 7,500 | $76.76 | $575,700.00 |
DisclosureSEC source: 0001061983-26-000087 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 377,820 Read SEC document |
| August 10, 2026 Filed Aug 10, 2026 21:11 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 7,500 | $10.60 | $79,500.00 |
DisclosureSEC source: 0001061983-26-000087 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 385,320 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2026 Filed Jul 27, 2026 20:33 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001061983-26-000085 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 179,245 Underlying: Common Stock · 7,500 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2026 Filed Jul 27, 2026 20:33 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 7,500 | $80.87 | $606,525.00 |
DisclosureSEC source: 0001061983-26-000085 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 377,820 Read SEC document |
| July 27, 2026 Filed Jul 27, 2026 20:33 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 7,500 | $10.60 | $79,500.00 |
DisclosureSEC source: 0001061983-26-000085 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 385,320 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 13, 2026 Filed Jul 14, 2026 19:34 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 7,490 | $0.00 Strike: $10.60 | $0.00 |
DisclosureSEC source: 0001061983-26-000077 · form4.xml · derivative · entry 6 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 186,745 Underlying: Common Stock · 7,490 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 13, 2026 Filed Jul 14, 2026 19:34 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 7,490 | $82.02 | $614,329.80 |
DisclosureSEC source: 0001061983-26-000077 · form4.xml · nonDerivative · entry 3 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 377,820 Read SEC document |
| July 13, 2026 Filed Jul 14, 2026 19:34 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 7,490 | $10.60 | $79,394.00 |
DisclosureSEC source: 0001061983-26-000077 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 385,310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 13, 2026 Filed Jul 14, 2026 19:34 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 10 | $82.02 | $820.20 |
DisclosureSEC source: 0001061983-26-000077 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 377,820 Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 21:20 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 7,500 | $84.92 | $636,900.00 |
DisclosureSEC source: 0001061983-26-000074 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 377,830 Read SEC document |
| June 15, 2026 Filed Jun 15, 2026 20:40 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 7,500 | $70.46 | $528,450.00 |
DisclosureSEC source: 0001061983-26-000068 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 385,330 Read SEC document |
| May 27, 2026 Filed May 28, 2026 20:21 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 7,500 | $77.21 | $579,075.00 |
DisclosureSEC source: 0001061983-26-000063 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 392,830 Read SEC document |
| May 14, 2026 Filed May 14, 2026 20:26 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 7,500 | $77.92 | $584,400.00 |
DisclosureSEC source: 0001061983-26-000052 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 400,330 Read SEC document |
| April 29, 2026 Filed Apr 29, 2026 20:23 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 7,500 | $59.62 | $447,150.00 |
DisclosureSEC source: 0001061983-26-000044 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 407,830 Read SEC document |
| April 15, 2026 Filed Apr 15, 2026 21:27 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 7,500 | $65.38 | $490,350.00 |
DisclosureSEC source: 0001061983-26-000035 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 415,330 Read SEC document |
| April 01, 2026 Filed Apr 1, 2026 20:34 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 7,500 | $66.63 | $499,725.00 |
DisclosureSEC source: 0001061983-26-000031 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 422,830 Read SEC document |
| March 17, 2026 Filed Mar 18, 2026 21:37 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 23,928 | $62.15 | $1,487,125.20 |
DisclosureSEC source: 0001061983-26-000026 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 430,330 F2 · kind: Company compelled sell-to-cover transaction to satisfy tax withholding obligations attributable to RSU vesting. Read SEC document |
| March 17, 2026 Filed Mar 18, 2026 21:37 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 12,673 | $62.15 | $787,626.95 |
DisclosureSEC source: 0001061983-26-000026 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 454,258 F1 · kind: Company compelled sell-to-cover transaction to satisfy tax withholding obligations attributable to RSU vesting. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 20:11 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 111,864 | $0.00 Strike: $60.06 | $0.00 |
DisclosureSEC source: 0001061983-26-000024 · form4.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,864 Underlying: Common Stock · 111,864 shares Expires 2036-03-14 F5 · kind: Annual equity award comprised of stock options that vest in 48 equal monthly installments, subject to officer's continued employment with the company on each vesting date. Stock options are subject to the company's Amended and Restated 2004 Equity Incentive Plan. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 20:11 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantIncentive Stock Option (Right to Buy) · Derivative | 1,665 | $0.00 Strike: $60.06 | $0.00 |
DisclosureSEC source: 0001061983-26-000024 · form4.xml · derivative · entry 4 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,665 Underlying: Common Stock · 1,665 shares Expires 2036-03-14 F4 · kind: Annual equity award comprised of stock options that vest in 48 equal monthly installments, subject to officer's continued employment with the company on each vesting date. Stock options are subject to the company's Amended and Restated 2004 Equity Incentive Plan. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 20:11 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantCommon Stock | 75,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-26-000024 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 466,931 F1 · kind: Annual equity award comprised of restricted stock units ("RSUs") that convert on a 1:1 basis for shares of our common stock. RSUs vest, subject to the officer's continued employment with the company, as follows: 40% of the RSUs on the 1-year anniversary of the grant date, an additional 40% of the RSUs on the 2-year anniversary of the grant date, and the final 20% of the RSUs on the 3-year anniversary of the grant date. RSUs are subject to the company's Amended and Restated 2004 Equity Incentive Plan. Read SEC document |
| March 09, 2026 Filed Mar 10, 2026 22:00 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 7,931 | $60.72 | $481,570.32 |
DisclosureSEC source: 0001061983-26-000016 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 391,673 F1 · kind: Sell to cover transaction to satisfy company tax withholding obligations upon vesting of RSUs. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:26 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionIncentive Stock Option (Right to Buy) · Derivative | 16,506 | $0.00 Strike: $6.67 | $0.00 |
DisclosureSEC source: 0001061983-25-000052 · form4.xml · derivative · entry 7 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,506 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:26 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 54,727 | $0.00 Strike: $6.67 | $0.00 |
DisclosureSEC source: 0001061983-25-000052 · form4.xml · derivative · entry 6 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 54,727 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:26 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 16,506 | $6.67 | $110,095.02 |
DisclosureSEC source: 0001061983-25-000052 · form4.xml · nonDerivative · entry 3 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 391,009 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Cash exercise and hold transaction. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:26 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Tax withholdingCommon Stock | 30,426 | $68.18 | $2,074,444.68 |
DisclosureSEC source: 0001061983-25-000052 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 374,503 F2 · kind: Shares represent withholding of shares to cover exercise price and tax withholding obligations resulting from the net share settlement of 54,727 non-qualified stock options. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:26 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 54,727 | $6.67 | $365,029.09 |
DisclosureSEC source: 0001061983-25-000052 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 404,929 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Net share settlement transaction. Not a market transaction. Read SEC document |
| December 22, 2025 Filed Dec 29, 2025 21:09 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Tax withholdingCommon Stock | 2,935 | $62.72 | $184,083.20 |
DisclosureSEC source: 0001061983-25-000056 · form4.xml · nonDerivative · entry 3 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 399,604 F3 · kind: Withholding of shares for tax on performance shares that have been earned and vested. Read SEC document |
| December 22, 2025 Filed Dec 29, 2025 21:09 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantCommon Stock | 5,765 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-25-000056 · form4.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 402,539 F2 · kind: Performance Stock Units earned upon achieving performance goal. Shares have been vested. Read SEC document |
| December 22, 2025 Filed Dec 29, 2025 21:09 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantCommon Stock | 5,765 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-25-000056 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 396,774 F1 · kind: Performance shares earned as a result of achieving performance goal. Shares remain subject to 1-year time vesting requirement. Read SEC document |
| December 03, 2025 Filed Dec 5, 2025 21:17 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Tax withholdingCommon Stock | 5,930 | $65.02 | $385,568.60 |
DisclosureSEC source: 0001061983-25-000043 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,202 Read SEC document |
| November 05, 2025 Filed Nov 5, 2025 21:22 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-25-000030 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 356,108 Read SEC document |
| October 30, 2025 Filed Oct 30, 2025 20:25 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $62.86 | $314,300.00 |
DisclosureSEC source: 0001061983-25-000027 · form4.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 358,108 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.